WWM
DNA icon

Western Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Western Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$83.1K – 963
2025
Q4 		$83.1K Buy
+10,000
New +$108K ﹤0.01% 825
2022
Q4 		– Sell
-383
Closed -$41K – 644
2022
Q3 		$41K Hold
383
– – ﹤0.01% 795
2022
Q2 		$49K Sell
383
-100
-21% -$12.2K ﹤0.01% 772
2022
Q1 		$78K Buy
+483
New +$94K ﹤0.01% 811

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Western Wealth Management's DNA Position: Q1 2026 in Review

Western Wealth Management sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 10,000 shares — an estimated $83.1K sold.

Western Wealth Management first reported a position in DNA in Q1 2022 and held it in 4 quarters. The position peaked at $83.1K in Q4 2025. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Western Wealth Management reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Western Wealth Management sold 10,000 Ginkgo Bioworks shares in Q1 2026, an estimated $83.1K.
  • Western Wealth Management first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 4 quarters.
  • Western Wealth Management's Ginkgo Bioworks position peaked at $83.1K in Q4 2025.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.